Equity Research, Broker Reports, and media content on Silence Therapeutics plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Silence Therapeutics plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Silence Therapeutics plc

Company Profile

  • Personnel
  • David Horn Solomon, CEO
  • Rob Quinn, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Silence Therapeutics plc. We currently have 59 research reports from 5 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 411/680p
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: £0m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
26Nov21 07:00 RNS Silence Therapeutics - Update on AIM Delisting
25Nov21 17:30 RNS FTSE Russell - Silence Therapeutics
16Nov21 07:00 RNS Silence Therapeutics - Third Quarter 2021 Financial Results
11Nov21 07:00 RNS Silence Therapeutics - Silence to Present at Jefferies London Conference
10Nov21 07:00 RNS Silence Therapeutics - Holding(s) in Company
05Nov21 07:00 RNS Silence Therapeutics - New Key Shareholder
01Nov21 17:33 RNS Silence Therapeutics - Result of General Meeting
  • Frequency of research reports

     

  • Research reports on

    Silence Therapeutics plc

  • Providers covering

    Silence Therapeutics plc